View Older Stories

Nov 25, 2025 12:46AM Canaccord Genuity Downgrades Exact Sciences (EXAS) to Hold

Nov 24, 2025 10:42AM Piper Sandler Downgrades Exact Sciences (EXAS) to Neutral

Nov 24, 2025 09:13AM Exact Sciences (EXAS) PT Raised to $105 at UBS as Abbott Deal Expected to Close in 2Q26

Nov 24, 2025 12:23AM Jefferies Downgrades Exact Sciences (EXAS) to Hold

Nov 21, 2025 10:14AM Craig-Hallum Downgrades Exact Sciences (EXAS) to Hold

Nov 21, 2025 07:14AM Nephron Downgrades Exact Sciences (EXAS) to Hold

Nov 20, 2025 04:12PM William Blair Downgrades Exact Sciences (EXAS) to Market Perform

Nov 20, 2025 04:01PM Wolfe Research Downgrades Exact Sciences (EXAS) to Peerperform

Nov 20, 2025 02:14PM BTIG Downgrades Exact Sciences (EXAS) to Neutral

Nov 20, 2025 01:43PM Citi Downgrades Exact Sciences (EXAS) to Neutral

Nov 20, 2025 12:20PM Leerink Partners Downgrades Exact Sciences (EXAS) to Market Perform

Nov 20, 2025 11:49AM Guggenheim Downgrades Exact Sciences (EXAS) to Neutral

Nov 20, 2025 10:17AM Baird Downgrades Exact Sciences (EXAS) to Neutral

Nov 20, 2025 09:43AM UBS Reiterates Neutral Rating on Exact Sciences (EXAS) Following Abbott Deal Reports

Nov 20, 2025 07:44AM Exact Sciences stock jumps after Abbott confirms acquisition

Nov 20, 2025 05:37AM Exact Sciences (EXAS) call put ratio 6.1 calls to 1 put with a focus on November calls

Nov 19, 2025 05:03PM Canaccord Genuity Reiterates Exact Sciences (EXAS) at Buy, 'view the shares as attractive following "takeout" speculation'

Nov 19, 2025 04:39PM BTIG Reiterates Exact Sciences (EXAS) at Buy, 'tie up between ABT and EXAS makes sense'

Nov 19, 2025 04:00PM Wolfe Research Reiterates Peerperform Rating on Abbott Labs (ABT)

Nov 19, 2025 02:48PM William Blair Reiterates Outperform Rating on Exact Sciences (EXAS)

Nov 19, 2025 01:49PM Exact Sciences (EXAS) resumes trading, up 28%

Nov 19, 2025 01:42PM Abbott reportedly nearing deal for Exact Sciences

Nov 19, 2025 01:42PM Exact Sciences (EXAS) halted on volatility, up 13.95%

Nov 7, 2025 08:02AM Exact Sciences blood test shows improved liver cancer detection

Nov 4, 2025 09:23AM Exact Sciences (EXAS) PT Raised to $80 at Stifel

Nov 4, 2025 06:11AM Exact Sciences (EXAS) PT Raised to $85 at BTIG

Nov 4, 2025 03:17AM Exact Sciences (EXAS) PT Raised to $85 at Canaccord Genuity

Nov 3, 2025 04:13PM Exact Sciences (EXAS) Tops Q3 EPS by 27c, provides guidance

Oct 27, 2025 07:02AM Exact Sciences presents colorectal cancer screening data at ACG 2025

Oct 8, 2025 08:56AM Exact Sciences (EXAS) PT Raised as Piper Sandler Sees a 'Compelling Investment Opportunity'

Oct 7, 2025 07:00AM Study finds Cologuard Plus delivers most life-years with fewest colonoscopies

Oct 7, 2025 06:13AM Evercore Adds Names to TAP Lists

Sep 30, 2025 08:34AM Exact Sciences (EXAS) PT Raised to $60 at Benchmark

Sep 10, 2025 06:30AM Exact Sciences launches Cancerguard multi-cancer blood test at $689

Aug 12, 2025 06:10AM Exact Sciences (EXAS) PT Lowered to $60 at BTIG

Aug 7, 2025 10:45AM Exact Sciences (EXAS) PT Lowered at RBC Capital on 'Long Term Uncertainty'

Aug 7, 2025 10:26AM Exact Sciences (EXAS) PT Lowered to $60 at Bernstein SocGen Group

Aug 7, 2025 09:59AM Exact Sciences (EXAS) PT Lowered at TD Cowen; 'Sell-Off Looks Overdone'

Aug 7, 2025 09:07AM Piper Sandler Reiterates Overweight Rating on Exact Sciences (EXAS)

Aug 6, 2025 04:12PM Exact Sciences (EXAS) Tops Q2 EPS by 12c, Updates Guidance

Aug 6, 2025 04:10PM Exact Sciences acquires exclusive license for Freenome blood-based CRC tests

Jul 31, 2025 07:02AM Exact Sciences expands Humana partnership for colorectal cancer screening

Jul 18, 2025 06:22AM Canaccord Genuity Reiterates Buy Rating on Exact Sciences (EXAS)

Jul 14, 2025 06:00AM Exact Sciences schedules Q2 2025 earnings call for August 6

Jul 10, 2025 03:09PM Exact Sciences (EXAS) Cancer-screening Patent Invalidated In Geneoscopy Win - Bloomberg Law

Jul 10, 2025 07:29AM William Blair Reiterates Outperform Rating on Exact Sciences (EXAS)

Jul 10, 2025 06:48AM Canaccord Genuity Reiterates Buy Rating on Exact Sciences (EXAS)

Jul 9, 2025 10:14AM Raymond James Upgrades Exact Sciences (EXAS) to Market Perform

Jul 9, 2025 06:01AM Exact Sciences gains Medicare coverage for colorectal cancer test

Jun 27, 2025 12:07PM Braidwood ruling positive for Exact Sciences (EXAS) and Guardant Health (GH) - Stifel

View Older Stories